Most of the data collected after organ transplantaBackground. The literature contains reports of 2309 tion on pregnancy to date have concerned patients pregnancies in some 1600 women who have undergone with renal allografts. With the recent advances in renal transplantation. Certain pre-pregnancy factors, immunosuppressive therapy, the transplantation of especially hypertension, renal graft dysfunction, short kidneys from other living related donors and even interval between transplant and pregnancy, and high cadaveric donors has also become possible. In all, 2309 immunosuppressive drug dosage, appear to increase pregnancies have been reported so far in~1600 renal the neonatal risks.
Material and methods Introduction
The study population included 27 women aged 20-40 years Organ transplantation has achieved tremendous sucwith a functioning renal allograft who were admitted to the cess and more patients have been able to return to a Hypertension in Pregnancy Clinic of Rabin Medical Center normal life, including bearing children.
(Beilinson Campus) in Israel and followed by local hospital specialists in perinatology, nephrology, and transplantation.
In 23 pregnancies, the patient had received the graft from 9 years). Ten of the 27 patients ( 31%) had episodes of a living donor, and in 19, from a cadaver donor. acute rejection prior to pregnancy. In 17 of the 42 Immunosuppression was maintained during all pregnancies. pregnancies (40%), the mother began pregnancy on Azathioprine ( AZA) 2-3 mg/kg/d was used in 33 out of anti-hypertensive medication. Mean serum creatinine the 42 pregnancies (79%), prednisone 7.5-10 mg/d values were 1.27±0.05 mg/dl (range, 0.7-4.1 mg/dl ). Using a logistic regression model, use of 7.5 mg/d inhibitors were advised to stop treatment at diagnosis of prednisone was found to be the most significant preconpregnancy.
ception parameter related to successful pregnancy outWe analysed several pre-pregnancy factors, including come (odds ratio 0.00001 for worse pregnancy health status, age, parity, type of renal allograft ( live donor outcome, P=0.0003). In the group treated with or cadaveric ), time interval from transplantation to concep-7.5 mg/d prednisone, 17 out of 17 pregnancies had a tion, episodes of acute rejection, evidence of hypertension, successful outcome, whereas in the 10 mg/d prednisone evidence of proteinuria (micro-or macroalbuminuria), and group, this was true for only 15 out of 25 pregnanrenal function (serum creatinine). The dose of the immunocies (60%).
suppressive drugs prior to pregnancy was also taken into Successful outcome was significantly related to an consideration.
Pregnancy outcome was rated on the basis of occurrence interval of more than 2 years from the time of transof spontaneous or therapeutic abortion, days of hospitaliza-plantation to conception (odds ratio=5.9, P=0.03). tion before delivery, occurrence of pre-eclampsia (defined as Lack of pre-existing hypertension was also significant initial diastolic blood pressure [DBP] ∏90 mmHg with an in predicting successful outcome (odds ratio=0.23, increase of at least 25 mmHg, to a DBP >90 mmHg, or P=0.05). None of the other pre-pregnancy factors initial DBP >90 mmHg with an increase of at least 15 mmHg studied, such as type of renal allograft (P=0.385), and evidence of more than 300 mg protein on 24-h urine number of episodes of acute rejection (P=0.19), evid- The interactions between prednisone dose (10 mg/d evaluated on long-term follow-up ( 2 years after pregnancy) or 7.5 mg/d ), interval from transplantation to concepwere maternal renal function and infant status ( incidence of tion ( long: >2 years, or short: <2 years), and presevere handicap).
existing hypertension in predicting pregnancy outcome Microalbuminuria was determined using a radioimmuno-are shown in Table 1 . We found that a renal transplant assay technique [10,11] after 8-h overnight urine collection. patient who received a pre-pregnancy prednisone dose A successful pregnancy outcome was defined as a live, of 10 mg/d and had a short interval from transplantahealthy infant without severe handicap 2 years after delivery.
tion to conception and pre-existing hypertension had
To predict the pregnancy outcome on the basis of the preonly a 10% chance of successful pregnancy outcome.
pregnancy health status and immunosuppressive therapy regimen stepwise logistic regression models were fitted.
A 7.5 mg/d prednisone dose was associated with a The probability of successful pregnancy outcome could be 100% chance of successful outcome, regardless of time calculated using the formula:
to conception or presence of hypertension. pregnancies (62%) the mothers were primiparas. One woman delivered three times and six patients aP: predicted probability of having successful pregnancy outcome delivered twice. The average interval from time of transplantation prednisone; OP1: 7.5 mg/d prednisone. c Short interval from transplantation to conception <2 years, long interval, >2 years.
to conception was 3.8±0.4 years (range, 2 months to Pregnancy outcome is summarized in Table 2 . Six and foetal distress. Our incidence of IUGR ( 33%) matched the findings in the literature (38%) [14, [16] [17] [18] [19] [20] . pregnancies (14%) ended in therapeutic abortion and None of the patients in the present study had a six in early spontaneous abortion. Thirty progressed rejection episode during pregnancy or in the early postbeyond the second trimester and 29 of them ended in delivery period, as expected from the literature a live birth. There was one case of intrauterine death [14, 15, 19] . Although it is quite difficult to distinguish in a twin pregnancy at 32 weeks of gestation; the cause hypertension from pre-eclampsia in women with transwas unknown.
plants [15, 19, 20] , superimposed pre-eclampsia In those cases that went beyond the first trimester, developed in five of 30 deliveries in the present study. there were five instances of superimposed pre-eclampsia Pre-eclampsia was diagnosed on the basis of significant ( 17%) and three of severe disease (10%). In 38% of clinical deterioration expressed as significantly high the pregnancies, the mother was hospitalized at least blood pressure, massive proteinuria, and liver and once; the average number of hospitalization days prior coagulation disturbances. to delivery was 13.5±4.2. Mean gestational age at Once the first trimester was successfully completed, delivery was 34.8±0.58 weeks; 63% of all deliveries the perinatal and maternal outcome in the majority of were pre-term (<37 weeks gestation).
the pregnancies was satisfactory (89%, successful pregThe IUGR rate was 33% and the caesarean section nancy outcome). Nevertheless, such pregnancies must rate, 37%. The average hospitalization time in the be considered high risk and should, if possible, be neonatal intensive care unit was 35.2±16.2 days. On carefully planned. Regarding the long-term follow-up follow-up, two of the 29 infants delivered (7%) were results, four women progressed to end-stage disease severely handicapped, mainly as a result of (9.5% of all pregnancies) and five (12%) demonstrated prematurity. a significant increase in serum creatinine. In the literatThree women ( 14%) progressed to end-stage renal ure of the last ten years, the overall five-year survival disease within 2 years of delivery. Two underwent rate for recipients of a living or cadaveric donor repeated renal transplantation and one is receiving transplant has been 88% and 71%, respectively [17] . haemodialysis. Four demonstrated a significant Guidelines for pre-pregnancy counselling of women increase in serum creatinine (>1 mg/dl ) within 2 years with renal allografts were published as early as 1976 of delivery.
[21]. With minor corrections, those guidelines are still cited in the literature, but the criteria are relative and some are controversial [1] . The results of the present Discussion study confirm the importance of pre-pregnancy counselling of renal allograft recipients. Over the last 20 years most renal transplantations in
In our patients use of a lower dose of prednisone Israel (total number, 1300) have been performed at (7.5 mg/d ) as compared with 10 mg/d before pregRabin Medical Center (Beilinson Campus). Therefore, nancy was observed as the most significant preconcepmost of the renal transplant recipients who have since tion parameter related to successful pregnancy become pregnant have been treated at our center.
outcome. Prednisone has been used during pregnancy The incidence of pregnancy in renal transplant recipi-to treat many conditions. Experimental data have ents in Israel ( 1/17 women of all ages) is almost equal suggested that steroids may cause congenital anomalto that in the Spanish [5 ] and Norwegian [12 ] popula-ies, such as cleft lip and palate, but this has not been tions, and lower than that reported in a South African documented in humans. Some complications in neohospital (21/122 recipients, 15-35 years of age) [13] .
nates exposed to prednisone during gestation, such as The incidence of prematurity in the general popula-adrenal insufficiency and thymic hypoplasia, have been tion varies from 5-15% [4], whereas in transplant only rarely reported [22] . This may be attributable to recipients it is much higher: 63% in our study, and the low ability of the drug to cross the placenta at the 45-60% in the literature [1, 2, [14] [15] [16] [17] [18] . This may be 1510 ratio of foetal-to-maternal blood concentrations attributed to the higher incidence of urinary tract of the active metabolite, prednisolone [17 ] . It has also infections and chronic prednisone use in renal trans-been suggested that premature rupture of the memplant recipients. It may also be a result of obstetric branes may be related to prednisone use owing to its interventions for uncontrolled hypertension, IUGR possible effect on connective tissue [20, 23] . With these potential problems in mind, the prednisone maintenance dose for immunosuppression in pregnancy should in a patient with no episodes of rejection for more 
